XENETIC BIOSCIENCES, INC. Other Non-Current Assets
XENETIC BIOSCIENCES, INC. (XBIO) had Other Non-Current Assets of $313.92 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-06
- 2026-06-30: Other Assets, Noncurrent $313.92K.
- 2026-03-31: Other Assets, Noncurrent $313.92K.
- 2025-12-31: Other Assets, Noncurrent $313.92K.
- 2025-09-30: Other Assets, Noncurrent $0.00.
| Period end | Other Assets, Noncurrent |
|---|---|
| 2026-06-30 | $313.92K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $313.92K 10-Q · filed 2026-05-12 |
| 2025-12-31 | $313.92K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-12 |
| 2025-03-31 | $313.92K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $313.92K 10-K · filed 2026-03-12 |
| 2024-09-30 | $1.02M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.02M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $1.02M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $1.02M 10-K · filed 2025-03-18 |
| 2023-09-30 | $704.43K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $704.43K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $844.43K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.07M 10-K · filed 2024-03-21 |
| 2022-09-30 | $1.41M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $1.09M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $1.09M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $1.09M 10-K · filed 2023-03-22 |
| 2021-09-30 | $704.43K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $715.90K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $725.51K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $809.99K 10-K · filed 2022-03-22 |
| 2020-09-30 | $704.43K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $704.43K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $704.43K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $1.21M 10-K · filed 2021-03-16 |
| 2019-09-30 | $709.11K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $715.39K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $724.79K 10-Q · filed 2019-05-13 |
| 2018-12-31 | $705.66K 10-K · filed 2020-03-26 |
| 2018-09-30 | $709.84K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $714.03K 10-Q · filed 2018-08-10 |
| 2018-03-31 | $718.16K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $724.71K 10-K · filed 2019-03-29 |
| 2017-09-30 | $31.83K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $43.38K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $54.88K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $66.34K 10-K · filed 2018-03-30 |
| 2016-09-30 | $81.06K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $97.24K 10-Q · filed 2016-08-15 |
| 2016-03-31 | $113.32K 10-Q · filed 2016-05-16 |
| 2015-12-31 | $129.31K 10-K · filed 2017-03-31 |
| 2015-09-30 | $145.88K 10-Q · filed 2015-11-16 |
| 2015-06-30 | $162.06K 10-Q · filed 2015-08-19 |
| 2015-03-31 | $178.14K 10-Q · filed 2015-05-20 |
| 2014-12-31 | $199.27K 10-K · filed 2016-03-30 |
| 2014-09-30 | $98.20K 10-Q · filed 2014-11-14 |
| 2014-06-30 | $105.57K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $112.93K 10-Q · filed 2014-05-20 |
| 2013-12-31 | $0.00 10-K · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |